ClinicalTrials.gg

How we know

Every link on this study, and who decided it

The study on the left, the conditions and drugs this site links it to, and on each link the judgments that made or checked it, by day and by judge. The top row is the record itself: each new version seen since tracking began. Dashed lines are links the registry record does not make itself. Select a link to see everything judged on it, or a mark for one decision with its reason and evidence.

21 links3 made here, not in the record21 judgments2 judges (the rules as one: Rule based)1 record change seen
Claude Opus 5.5Rule basedRecord updated on ClinicalTrials.govMade here
Oct 19Oct 26Nov 2Nov 9Nov 16TodayNCT05594095SNF Platform Study of HR+/HER2-advanced Breast CancerFudan UniversityPhase 2 · recruitingRECORDThe record itselfVersions seen nightly since Sep 25, 2…›Nov 8 · ClinicalTrials.gov record · MeSH filing re-derivedMeSH filing re-derivedCONDITIONSBreast NeoplasmsThe registry's MeSH filing›As of now · Rule based · Main conditionMain conditionDRUGSINT012044Entry “PIK3CA inhibitor”, read by our…›Nov 18 · Rule based · TestedTestedINT010053Entry “AKT inhibitor”, read by our na…›Nov 18 · Rule based · TestedTestedCamrelizumabEntry “Carrelizumab”, read by our nam…›Nov 18 · Rule based · TestedTestedFamitinibIntervention entry›Nov 18 · Rule based · TestedTestedFluzoparibIntervention entry›Nov 18 · Rule based · TestedTestedDalpiciclibIntervention entry›Nov 18 · Rule based · TestedTestedTrastuzumab rezetecanEntry “SHR-A1811”, read by our name r…›Nov 18 · Rule based · TestedTestedEverolimusIntervention entry›Nov 18 · Rule based · TestedTestedGoserelinIntervention entry›Nov 18 · Rule based · TestedTestedSorafenibIntervention entry›Nov 18 · Rule based · TestedTestedApatinibIntervention entry›Nov 18 · Rule based · TestedTestedTizetatug rezetecanEntry “SHR-A1921”, read by our name r…›Nov 18 · Rule based · TestedTestedNotiretatug rezetecanEntry “SHR-A2102”, read by our name r…›Nov 18 · Rule based · TestedTestedRuzaltatug rezetecanEntry “SHR-A2009”, read by our name r…›Nov 18 · Rule based · TestedTestedINT029744Entry “SHR-1167”, read by our name ru…›Nov 18 · Rule based · TestedTestedINT029815Entry “SHR-6209”, read by our name ru…›Nov 18 · Rule based · TestedTestedBevacizumabIntervention entry›Nov 18 · Rule based · BackgroundBackgroundFulvestrantMade here · Found by reading; no entr…›Nov 3 · Claude Opus 5.5 · Background · partnerBackground · partnerAnastrozoleMade here · Found by reading; no entr…›Nov 10 · Claude Opus 5.5 · Background · optionBackground · optionExemestaneMade here · Found by reading; no entr…›Nov 10 · Claude Opus 5.5 · Background · optionBackground · option

Times are in your time zone; a day marked “day only” kept no time. The graph scrolls sideways on a narrow screen; every mark is also in the list below.

Fulvestrant

Made here1 judgment on this link
NCT05594095gives it, found by reading the recordFulvestrantDefined by Claude Opus 5.5Nov 3, 2026, 1:53 PM UTC
Role in the study, from the registry to what was judged
RegistryNot in the recordno intervention entry names it
→judged

All judgments on this study

WhenLinkJudgeDecisionState
Nov 3Fulvestrantmade hereClaude Opus 5.5Background · partnerCurrent
Nov 8The record itselfClinicalTrials.gov recordMeSH filing re-derivedRecord change
Nov 10Anastrozolemade hereClaude Opus 5.5Background · optionCurrent
Nov 10Exemestanemade hereClaude Opus 5.5Background · optionCurrent
Nov 18INT012044Rule based · role ruleTestedCurrent
Nov 18INT010053Rule based · role ruleTestedCurrent
Nov 18CamrelizumabRule based · role ruleTestedCurrent
Nov 18FamitinibRule based · role ruleTestedCurrent
Nov 18FluzoparibRule based · role ruleTestedCurrent
Nov 18DalpiciclibRule based · role ruleTestedCurrent
Nov 18Trastuzumab rezetecanRule based · role ruleTestedCurrent
Nov 18EverolimusRule based · role ruleTestedCurrent
Nov 18GoserelinRule based · role ruleTestedCurrent
Nov 18SorafenibRule based · role ruleTestedCurrent
Nov 18ApatinibRule based · role ruleTestedCurrent
Nov 18Tizetatug rezetecanRule based · role ruleTestedCurrent
Nov 18Notiretatug rezetecanRule based · role ruleTestedCurrent
Nov 18Ruzaltatug rezetecanRule based · role ruleTestedCurrent
Nov 18INT029744Rule based · role ruleTestedCurrent
Nov 18INT029815Rule based · role ruleTestedCurrent
Nov 18BevacizumabRule based · role ruleBackgroundCurrent
As of nowBreast NeoplasmsRule based · main-condition ruleMain conditionCurrent

The rules, in plain words

“Rule based” means one of these decided, not a model or a person. Each runs every night over every study.

Which drugs a study tests

Reads each treatment the study lists and the arms it is in. A drug only in the experimental arm is tested. A drug in every arm while something else changes between the arms is given beside it. A drug only in the control arm is the comparator. Placebo, procedures and usual care are known by name.

Where the whole record has been read, that reading's answer replaces the rule's.

What a study is mainly about

Starts from the first condition ClinicalTrials.gov files the study under. It moves to a narrower one only when the study's own title or listed conditions name it, and sets aside terms the registry often files by mistake. A study open to many cancers is not placed under one of them unless its title names it.

Checked against studies judged one by one; the study page says when it differs from the registry.